Evidence Based Probiotic Therapy of Proton Pump Inhibitor Induced Dysbiosis (EBP)
Dysbiosis
About this trial
This is an interventional treatment trial for Dysbiosis
Eligibility Criteria
Inclusion Criteria: Age >18; Signed Informed Consent; PPI intake for at least 3 months; Willing to accept use of all encoded data, including publication, and the confidential use and storage of all data for at least 15 years; Exclusion criteria Diagnosed with a gastrointestinal infection within 4 weeks prior to screening; Severe gastrointestinal disorders (e.g. inflammatory bowel diseases) Received any of the following products/medication prior to screening: systemic antibiotics, prokinetics, prebiotic supplements, probiotic supplements within 4 weeks prior to screening; Concomitant diseases or other circumstances that suggest that the patients are not eligible for participation in the study
Sites / Locations
- Medical University GrazRecruiting
Arms of the Study
Arm 1
Experimental
Intervention
The study product contains Lactobacillus acidophilus W53, Lactobacillus acidophilus W55, Lactobacillus casei W56, Lactobacillus plantarum W1, Lactobacillus plantarum W21, Lactobacillus rhamnosus W71, and Pediococcus acidilactici W143.